DRIO DARIOHEALTH CORP

Ownership history in MORGAN STANLEY  ·  22 quarters on record

This page tracks every 13F SEC filing in which MORGAN STANLEY reported a position in DARIOHEALTH CORP (DRIO). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 61 -5,111 -98.8% 0.00% $1K $17.35
2025 Q1 REDUCED 5,172 -95,645 -94.9% 0.00% $3K $12.24
2024 Q2 REDUCED 100,817 -3,308 -3.2% 0.00% $120K $23.80
2024 Q1 ADDED 104,125 +16,860 +19.3% 0.00% $159K $30.60
2023 Q4 ADDED 87,265 +30,691 +54.2% 0.00% $150K $34.40
2023 Q3 ADDED 56,574 +37,407 +195.2% 0.00% $186K $65.60
2023 Q2 REDUCED 19,167 -15,972 -45.5% 0.00% $77K $80.20
2023 Q1 REDUCED 35,139 -5,126 -12.7% 0.00% $145K $82.40
2022 Q4 REDUCED 40,265 -3,765 -8.6% 0.00% $172K $85.60
2022 Q3 ADDED 44,030 +18,337 +71.4% 0.00% $204K $92.60
12 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    DRIO price (monthly, adj. close)
← Back to MORGAN STANLEY Holdings